A pharmaceutical company that translates expertise in cardiovascular signaling pathways into therapeutics for patients.
investor of
Metrics
marketPRIVATE
msh_idCOM:CARDURION
websitehttps://cardurion.com
source_ref76b021bc-a82c-451d-a63f-6a021e4d20c7
company_size11
products_or_servicesDiscovery of new targets and novel drug candidates, acquisition of assets for CV disease, and innovation using adaptive trial designs and precision medicine approaches.